Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8642604

    Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents

    The Regents of the University of California · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8642770

    Indole derivative

    Takeda Pharmaceutical Company Limited · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8642788

    Activators of executioner procaspases 3, 6 and 7

    The Regents of the University of California · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8642656

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Regents of the University of Minnesota · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8642738

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8642741

    Human antibodies to human TNF-like ligand 1A (TL1A)

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8642653

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8642784

    Biologically active compound N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride with anti-inflammatory activity

    Obschestvo S Ogranichennoy Otvetstvennostyu “Polyar” (OOO Polyar) · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8642648

    Orally dispersible tablet

    Takeda Pharmaceutical Company Limited · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8642751

    MicroRNA inhibitors comprising locked nucleotides

    MIRAGEN THERAPEUTICS, INC. · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8646461

    Device and method for simulating chemosensation of smoking

    Sentiens, LLC · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8647646

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8647842

    Methods for producing a fusion protein capable of binding VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8648105

    Diarylthiohydantoin compounds

    The Regents of the University of California · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8648079

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8647818

    Molecular scaffolds for HIV-1 immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8647670

    Biocompatible rapid-gelating hydrogel and associated preparation method of spray

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8648119

    Controlled release immunomodulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8647837

    Artificial tissue constructs comprising alveolar cells and methods for using the same

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8648100

    Roflumilast for the treatment of pulmonary hypertension

    TAKEDA GMBH · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8648112

    Therapeutic uses of urolithins

    The Regents of the University of California · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8648072

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8648059

    Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling

    The Regents of the University of California · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8648102

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8648067

    Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands

    Teva Sante · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8648037

    Macrocyclic proline derived HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8647633

    Recombinant F1-V plague vaccine

    The United States of America as represented by the Secretary of the Army · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8646246

    Method of preparing a composition in blister packages

    Quantum Hi-Tech (Beijing) Research Institute · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8647637

    Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs

    The Board of Regents for Oklahoma State University · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. PH 12013502690

    ANTIBODIES TO ADP-RIBOSYL CYCLASE 2

    BERLIN CHEMIE AG [DE] · Granted Mon Feb 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Sun Feb 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8653103

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8653070

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8652366

    Aerosol-mediated particle synthesis

    The Board of Regents of the University of Texas System · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8652458

    Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8653027

    Method of treatment of type-1 diabetes with humanin analogues

    The Regents of the University of California · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8652443

    Foamable microemulsion compositions for topical administration

    Precision Dermatology, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8652445

    Dental compositions with sensitivity relief

    DISCUS DENTAL, LLC · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8652516

    Doxycycline formulations, and methods of treating rosacea

    Cerovene, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8652467

    Dek protein compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8652475

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8653057

    Prophylactic perioperative testosterone supplementation for protection of and recovery of function

    The Regents of the University of California · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8652503

    Bone paste

    Regeneration Technologies, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8652836

    Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response

    Providence Health System · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8653033

    Method for administering omega-conopeptide

    Jazz Pharmaceuticals International III Limited · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8653034

    Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

    The Board of Regents of the University of Texas System · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8652512

    Nebulized liposomes for the pulmonary application of drug compounds

    United Therapeutics Corporation · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8653060

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8652492

    Wet granulation using a water sequestering agent

    Rigel Pharmaceuticals, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.